Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 12:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 33,180 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Placebo Clear all

Conditions: Healthy Participants
Interventions: BLU-808, Placebo, Midazolam; Drug
Lead sponsor: Blueprint Medicines Corporation; Industry
Eligibility: 19 Years to 65 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Asthma
Interventions: Ginger Extract, Placebo; Drug
Lead sponsor: Emily DiMango, MD; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Safety Issues
Interventions: GB002, Generic Dry Powder Inhaler, Placebo; Drug · Device
Lead sponsor: GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Acute Pain, Bunion, Abdominoplasty
Interventions: Wafermine™ 50 mg, Wafermine™ 75 mg, Placebos, Wafermine™ 25 mg; Drug
Lead sponsor: iX Biopharma Ltd.; Other
Eligibility: 18 Years to 75 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Osteoarthritis, Knee
Interventions: Sprifermin, Placebo; Drug
Lead sponsor: EMD Serono Research & Development Institute, Inc.; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 549 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 2
States / cities: Lakewood, Colorado • Baltimore, Maryland

Conditions: Heart Failure
Interventions: Sodium Zirconium Cyclosilicate, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 150 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 14
States / cities: National City, California • Stanford, California • Waterbury, Connecticut + 11 more

Conditions: Psoriasis
Interventions: Deucravacitinib, Placebo; Drug · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 14
States / cities: Hot Springs, Arkansas • Indianapolis, Indiana • Louisville, Kentucky + 11 more

Conditions: Breast Cancer
Interventions: Soy, Milk; Dietary Supplement
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Female only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Post Traumatic Stress Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Cognitive Processing Therapy, Repetitive Transcranial Magnet Stimulation (rTMS); Device · Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 18 Years to 60 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Opioid Use Disorder
Interventions: Inhaled vaporized cannabis, Intransal opioid; Drug
Lead sponsor: Shanna Babalonis, PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Bipolar Disorder
Interventions: Valacyclovir, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: GTS21/Placebo; Drug
Lead sponsor: CoMentis; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Durham, North Carolina

Conditions: Osteoporosis
Interventions: PTH/Calcium, PTH/placebo, placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 45 Years and older · Female only
Enrollment: 374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 17
States / cities: Rancho Cucamonga, California • Lake Worth, Florida • Coeur d'Alene, Idaho + 14 more

Conditions: Major Depressive Disorder
Interventions: Fluoxetine, Placebo; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 14 Years to 18 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Human Microbiome
Interventions: Synbiotic, Probiotic, Placebo; Dietary Supplement
Lead sponsor: University of California, San Diego; Other
Eligibility: 65 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: La Jolla, California

Conditions: COVID-19, SAR
Interventions: CBDRA60 supplement, Placebo; Dietary Supplement
Lead sponsor: Anewsha Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Hanover, Michigan

Conditions: Recent Onset type1 Diabetes
Interventions: Ladarixin, Placebo; Drug
Lead sponsor: Dompé Farmaceutici S.p.A; Industry
Eligibility: 14 Years to 45 Years
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 25
States / cities: Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 20 more

Conditions: Retinitis Pigmentosa, X-linked Genetic Diseases
Interventions: docosahexaenoic acid OR corn/soy oil placebo; Drug
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 7 Years to 32 Years · Male only
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Major Depressive Disorder
Interventions: SR58611A; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 476 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Psoriasis
Interventions: PF-06826647 or Placebo, PF-06826647; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 24
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Anaheim, California + 13 more

Conditions: Gastroenteritis, Gastritis
Interventions: RHB-102, Placebo Oral Tablet; Drug
Lead sponsor: RedHill Biopharma Limited; Industry
Eligibility: 12 Years to 85 Years
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 26
States / cities: Bakersfield, California • Sacramento, California • Sylmar, California + 19 more

Conditions: Type 2 Diabetes Mellitus
Interventions: dutogliptin, placebo; Drug
Lead sponsor: Phenomix; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 34
States / cities: Montgomery, Alabama • Tempe, Arizona • Anaheim, California + 27 more

Conditions: Breast Cancer
Interventions: Seaweed and Soy Protein, Placebo and Soy Protein; Dietary Supplement
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 1999
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Transgender Persons
Interventions: Progesterone 200 MG, Placebo; Drug
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Study of BLU-808 in Healthy Adult Participants

Ginger's Therapeutic Potential in Asthma

Phase 1A Safety Trial of Inhaled PK10571 (GB002)

Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain

A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee

Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study

Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)

Cannabis and Opioid Use Disorder

Research Study of Bipolar Mood Symptoms and Cognitive Problems

Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder

Calcium Supplementation in Postmenopausal Women

Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation

(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

DHA and X-Linked Retinitis Pigmentosa

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Brown Seaweed as a Breast Cancer Preventive

Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen